We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+1.73%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
AUM
$133M
AUM Growth
+$12.3M
Cap. Flow
+$159M
Cap. Flow %
119.43%
Top 10 Hldgs %
64.36%
Holding
198
New
107
Increased
15
Reduced
33
Closed
27

Top Buys

Rank Stock Value
1
ISRL
Isramco Inc
ISRL
+$171M
2
NXPI icon
NXP Semiconductors
NXPI
+$3.94M
3
SILC icon
Silicom
SILC
+$1.15M
4
VUZI icon
Vuzix
VUZI
+$672K
5
MX icon
Magnachip Semiconductor
MX
+$659K

Sector Composition

Rank Sector Weight
1 Technology 12.17%
2 Healthcare 4%
3 Industrials 1.57%
4 Energy 1.32%
5 Consumer Discretionary 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVA icon
51
DaVita
DVA
$15.5B
$274K 0.21%
+3,826
New +$270K
APC
52
DELISTED
Anadarko Petroleum
APC
$273K 0.21%
+4,057
New +$274K
RNTX
53
CALL
Rein Therapeutics
RNTX
$64.8M
$257K 0.19%
+1,125
New +$75.7K
BTE icon
54
Baytex Energy
BTE
$2.96B
$247K 0.19%
+84,836
New +$260K
QUIK icon
55
QuickLogic
QUIK
$211M
$230K 0.17%
+16,429
New +$249K
NXPI icon
56
PUT
NXP Semiconductors
NXPI
$60.8B
$209K 0.16%
+44,000
New +$4.22M
GIB icon
57
CGI
GIB
$15.4B
$207K 0.16%
3,209
-1,880
-37% -$122K
ITCI
58
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$207K 0.16%
60,000
-29,000
-33% -$606K
NXST icon
59
Nexstar Media Group
NXST
$6.01B
$205K 0.15%
2,524
-5,636
-69% -$443K
EXPE icon
60
Expedia Group
EXPE
$36.5B
$202K 0.15%
1,550
-2,555
-62% -$332K
INSM icon
61
PUT
Insmed
INSM
$22.4B
$178K 0.13%
76,400
-17,600
-19% -$397K
CORV
62
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$173K 0.13%
+43,000
New +$190K
BDSI
63
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$167K 0.13%
+70,000
New +$196K
ISRL
64
DELISTED
Isramco Inc
ISRL
$167K 0.13%
+1,431,809
New +$171M
BAC icon
65
Bank of America
BAC
$429B
$166K 0.12%
+5,626
New +$171K
MLNX
66
DELISTED
Mellanox Technologies, Ltd.
MLNX
$164K 0.12%
2,237
-2,050
-48% -$165K
ERF
67
DELISTED
Enerplus Corporation
ERF
$149K 0.11%
+12,060
New +$152K
GOOG icon
68
Alphabet (Google) Class C
GOOG
$4.11T
$143K 0.11%
2,400
-6,100
-72% -$365K
AXSM icon
69
Axsome Therapeutics
AXSM
$11.7B
$138K 0.1%
+40,000
New +$119K
TLRA
70
DELISTED
Telaria, Inc.
TLRA
$133K 0.1%
+35,000
New +$135K
VVUS
71
DELISTED
Vivus Inc
VVUS
$132K 0.1%
+30,000
New +$188K
CNQ icon
72
Canadian Natural Resources
CNQ
$96.9B
$131K 0.1%
+8,188
New +$139K
KMX icon
73
CarMax
KMX
$8.39B
$129K 0.1%
1,731
-5,519
-76% -$421K
LSTR icon
74
Landstar System
LSTR
$6.04B
$129K 0.1%
1,056
-819
-44% -$94.8K
IWM icon
75
PUT
iShares Russell 2000 ETF
IWM
$79.1B
$123K 0.09%
+60,000
New +$10.1M

Similar funds

Worth Venture Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Worth Venture Partners held 198 positions worth $133M, up 10% from $121M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Worth Venture Partners deployed $159M of net new capital in Q3 2018, opening 107 new positions and adding to 15 existing holdings. Its largest new stake was Isramco Inc: 1,431,809 shares worth $167K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 6.6% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Illumina, an estimated $2.87M trimmed.

  • Worth Venture Partners's largest Q3 2018 buy was Isramco Inc: 1,431,809 shares worth $167K.
  • Worth Venture Partners added most to Kamada in Q3 2018, an estimated $597K increase.
  • Worth Venture Partners's biggest Q3 2018 reduction was Illumina, cutting an estimated $2.87M.
  • Worth Venture Partners fully exited Western Digital in Q3 2018, selling an estimated $1.44M.
  • Worth Venture Partners's ten largest holdings make up 64% of its $133M portfolio in Q3 2018.
  • Worth Venture Partners opened 107 new positions and closed 27 in Q3 2018.
  • Worth Venture Partners's portfolio value rose 10% quarter-over-quarter to $133M.

Based on Worth Venture Partners's 13F filing for Q3 2018, filed 15 Nov 2018.